Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

chronic lymphocytic leukemia

  • You have access
    Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors
    TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, SIVAM GAZIT, TAL PATALON and LIOR ROKACH
    Anticancer Research May 2024, 44 (5) 2109-2115; DOI: https://doi.org/10.21873/anticanres.17016
  • You have access
    Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
    BARTOSZ PULA, ELZBIETA ISKIERKA-JAZDZEWSKA, MONIKA DLUGOSZ-DANECKA, AGNIESZKA SZYMCZYK, MAREK HUS, AGNIESZKA SZEREMET, JOANNA DROZD-SOKOLOWSKA, ANNA WASZCZUK-GAJDA, JAN M. ZAUCHA, JADWIGA HOLOJDA, WERONIKA PISZCZEK, PAWEL STECKIEWICZ, MALGORZATA WOJCIECHOWSKA, MICHAL OSOWIECKI, WANDA KNOPINSKA-POSLUSZNY, MAREK DUDZINSKI, DARIA ZAWIRSKA, EDYTA SUBOCZ, JANUSZ HALKA, ANDRZEJ PLUTA, RYSZARD WICHARY, BEATA KUMIEGA, BOZENA K. BUDZISZEWSKA, WOJCIECH JURCZAK, EWA LECH-MARANDA, KRZYSZTOF GIANNOPOULOS, TADEUSZ ROBAK and KRZYSZTOF JAMROZIAK
    Anticancer Research July 2020, 40 (7) 4059-4066; DOI: https://doi.org/10.21873/anticanres.14403
  • You have access
    mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both In Vitro and In Vivo
    HUI-FEN LIAO, YOU-ZHU LIN, CHIH-CHIA YU, TZONG-SHYUAN TAI, SHIH-KAI HUNG, CHING-CHIEH YANG and YU-CHIEH SU
    Anticancer Research September 2019, 39 (9) 4829-4835; DOI: https://doi.org/10.21873/anticanres.13668
  • You have access
    Overexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report
    ZUZANA MICHALOVÁ, MATÚŠ ČOMA, MIROSLAVA KIČOVÁ, JULIANA GABZDILOVÁ, KINGA DEDINSKÁ, TOMÁŠ GUMAN, MARTINA HÁJIKOVÁ, DOMINIKA VESELINYOVÁ, MÁRIA GIERTLOVA, PETER GÁL and MAREK ŠARIŠSKÝ
    Anticancer Research June 2019, 39 (6) 2805-2810; DOI: https://doi.org/10.21873/anticanres.13408
  • You have access
    Expression and Effects of Ligand-activated Estrogen Receptors in Chronic Lymphocytic Leukemia
    MOHAMMAD SHARIF HASNI and KONSTANTIN YAKIMCHUK
    Anticancer Research January 2019, 39 (1) 167-172; DOI: https://doi.org/10.21873/anticanres.13093
  • You have access
    Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
    BARTOSZ PUŁA, BOŻENA KATARZYNA BUDZISZEWSKA, JUSTYNA RYBKA, LIDIA GIL, EDYTA SUBOCZ, MONIKA DŁUGOSZ-DANECKA, DARIA ZAWIRSKA, ANNA WASZCZUK-GAJDA, ELŻBIETA ISKIERKA-JAŻDŻEWSKA, AGNIESZKA KOPACZ, AGNIESZKA SZYMCZYK, JAROSŁAW CZYŻ, EWA LECH-MARAŃDA, KRZYSZTOF WARZOCHA and KRZYSZTOF JAMROZIAK
    Anticancer Research May 2018, 38 (5) 3025-3030;
  • You have access
    Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia
    GORDON T. BOLGER, ALBERT LICOLLARI, AIMIN TAN, RICHARD GREIL, LISA PLEYER, BRIGITTA VCELAR, MUHAMMAD MAJEED and PETER SORDILLO
    Anticancer Research January 2018, 38 (1) 121-130;
  • You have access
    Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
    SOTIRIOS SACHANAS, GERASSIMOS A. PANGALIS, MARIA MOSCHOGIANNIS, XANTHI YIAKOUMIS, EFSTATHIOS KOULIERIS, PANTELIS TSIRKINIDIS, CHRISTINA KALPADAKIS and DIMITRA RONTOGIANNI
    Anticancer Research June 2017, 37 (6) 3277-3280;
  • You have access
    Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation
    PANAGIOTIS T. DIAMANTOPOULOS, STAVROULA SAMARA, PANAGOULA KOLLIA, NEFELI GIANNAKOPOULOU, MARIA SOFOTASIOU, FANI KALALA, ELINA KODANDREOPOULOU, PANAGIOTIS ZERVAKIS, THEODOROS VASSILAKOPOULOS, MARINA SIAKANTARIS, MARINA MANTZOURANI, MARIA ANGELOPOULOU, MARIE-CHRISTINE KYRTSHONIS, PENELOPE KORKOLOPOULOU, EFSTATHIOS PATSOURIS and NORA-ATHINA VINIOU
    Anticancer Research May 2017, 37 (5) 2387-2391;
  • You have access
    Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report
    SOTIRIOS SACHANAS, GERASSIMOS A. PANGALIS, PETROS KAROUZAKIS, EFSTATHIOS KOULIERIS, MARIA MOSCHOGIANNIS, CHRISTINA KALPADAKIS, XANTHI YIAKOUMIS and DIMITRA RONTOGIANNI
    Anticancer Research September 2016, 36 (9) 4759-4762;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire